Home > Updates>Latest
SIPA, AstraZeneca discuss pharmaceutical IP protection

SIPA, AstraZeneca discuss pharmaceutical IP protection

November 18, 2026

Scott Alban, AstraZeneca's senior vice president for global intellectual property, led a delegation to the SIPA on Nov 9.

SIPA completes IP protection work for ninth CIIE with zero complaints

SIPA completes IP protection work for ninth CIIE with zero complaints

November 17, 2026

The SIPA has completed its IP services and protection for the ninth CIIE, held from Nov 5 to 10, with zero IP disputes reported during the event.

Shanghai's promise to innovators around the world

Shanghai's promise to innovators around the world

November 16, 2026

Shanghai is putting its commitment to innovators worldwide into practice by strengthening IP protection, supporting commercialization and fostering international exchange.

Huangpu IP services help medical innovations reach market

Huangpu IP services help medical innovations reach market

November 11, 2026

Market approval for China's first domestically developed auditory brainstem implant has been secured on Oct 20.

Changning issues Hongqiao's first data IP certificate for AI firms going global

Changning issues Hongqiao's first data IP certificate for AI firms going global

November 10, 2026

ThinkingAI has completed intellectual property evidence registration for its AI agent platform, Agentic Engine.

Pudong firms sign first overseas IP protection insurance policies

Pudong firms sign first overseas IP protection insurance policies

November 9, 2026

A total of 19 companies have signed up for the first batch of an overseas intellectual property protection insurance product launched by PICC on Oct 22

SIPA pledges equal protection for US businesses

SIPA pledges equal protection for US businesses

November 6, 2026

A delegation led by Meredith Champlin, deputy consul general at the US Consulate General in Shanghai, and Courtney Stopp of USPTO visited SIPA on Nov 3.

SIPA discusses biopharma protection with AbbVie

SIPA discusses biopharma protection with AbbVie

November 4, 2026

AbbVie delegation met with the Shanghai Intellectual Property Administration officials on Oct 27 for talks on biopharma IP protection.

1 2 3 ... 65 >

Links
copyright ©  Shanghai Intellectual Property Administration.
All rights reserved. Presented by China Daily.
京ICP备13028878号-94